וירו-מרץ ג'ל
megapharm ltd - tromantadine hydrochloride 1 % - gel - tromantadine - for the treatment of herpes simplex virus infections and dermanl manifestations of herpes zoster.
זובירקס ג'ניטל
glaxo smith kline (israel) ltd - aciclovir - קרם - aciclovir 5 %w/w - aciclovir - aciclovir - for local treatment of genital herpes simplex.
ציקלומד קרם
mediline ltd. - aciclovir 5 %w/w - cream - aciclovir - for the treatment of herpes simplex virus infection of the lips (herpes labialis) and cold sores.
זובירקס משחת עיניים
glaxo smith kline (israel) ltd - aciclovir - משחה לעין - aciclovir 3 %w/w - aciclovir - aciclovir - indicated for the treatment of herpes simplex keratitis.
וי-ראל
vitamed ltd,binyamina - aciclovir 5 g / 100 g - ointment - antivirals - for local treatmet of viral infections and labial herpes simplex.
נוקלה אבקה להכנת תמיסה להזרקה
glaxo smith kline (israel) ltd - mepolizumab - אבקה להכנת תמיסה לזריקה - mepolizumab 100 mg - mepolizumab
נוקלה תמיסה להזרקה
glaxo smith kline (israel) ltd - mepolizumab - תמיסה להזרקה - mepolizumab 100 mg / 1 ml - mepolizumab
אנספרינג
roche pharmaceuticals (israel) ltd - satralizumab - תמיסה להזרקה - satralizumab 120 mg / 1 ml - satralizumab
רמסימה 100 מג תוך-ורידי
padagis israel agencies ltd, israel - infliximab - אבקה להכנת תמיסה מרוכזת לעירוי - infliximab 100 mg/vial - infliximab
פלומיסט קואדריוואלנט
astrazeneca (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - ספריי לאף - b/phuket/3073/2013 (b/yamagata lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/darwin/9/2021 (h3n2)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 7 ±0.5 log10 ffu^a / 0.2 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - flumist quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses ad type b viruses contained in the vaccine. flumist quadrivalent is approved for use in persons 2 through 49 years of age.